Tempus AI, Inc.
Tempus AI, Inc.'s purchase track record
How the stock did after each of Tempus AI, Inc.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/17/2025 | TEM | $996K | -24.6% | -24.5% | +10.4% |
| 11/18/2025 | TEM | $1.74M | -21.3% | -31.8% | +11.1% |
| 8/16/2024 | PSNL | $17.75M | -35.1% | -8.0% | +10.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Competitors Tempus and Natera draw market attention. Recent news highlights increased activity by Personalis competitors. Tempus AI is expanding its cancer vaccine infrastructure with Moderna and Merck, while Natera faces rising competitive threats. These developments underscore the crowded nature of the precision medicine sector, providing context for Personalis's current trading position near its support levels.
Transaction History
| TEM | ▲ Buy | Open Market | 28,000 | $250K | 12/22/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 29,641 | $249K | 12/19/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 31,430 | $249K | 12/18/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 31,650 | $249K | 12/17/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 13,888 | $153K | 11/25/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 9,712 | $98K | 11/25/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 25,225 | $249K | 11/24/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 9,900 | $88K | 11/21/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 16,599 | $162K | 11/21/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 28,827 | $249K | 11/20/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 30,645 | $249K | 11/19/2025 | View on chart |
| TEM | ▲ Buy | Open Market | 64,750 | $497K | 11/18/2025 | View on chart |
| PSNL | ▲ Buy | Open Market | 3,500,000 | $17.7M | 8/16/2024 | View on chart |
| PSNL | ▼ Sell | Other | 4,609,400 | $6.9M | 8/16/2024 | View on chart |
| PSNL | ▼ Sell | Other | 4,609,400 | $11.5M | 8/16/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Tempus AI Expands Collaborations, Canaccord Raises Target to $95
Tempus AI is expanding its strategic collaborations to support future growth. Canaccord Genuity recently raised its price target for the stock to $95. This development occurs as the company prepares to report its third-quarter financial results on November 2.
Tempus AI Expands Collaborations, Canaccord Raises Target to $95. Tempus AI is expanding its strategic collaborations to support future growth. Canaccord Genuity recently raised its price target for the stock to $95. This development occurs as the company prepares to report its third-quarter financial results on November 2.